Zai Lab (ZLAB) News Today $26.72 +0.50 (+1.91%) (As of 12/20/2024 05:30 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Zai Lab Announces Participation in Investor Conference in January 2025December 12, 2024 | businesswire.comFmr LLC Sells 487,202 Shares of Zai Lab Limited (NASDAQ:ZLAB)Fmr LLC trimmed its stake in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 43.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 644,859 shares of the company's stock after selling 487,202 shDecember 11, 2024 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) Holdings Boosted by Wellington Management Group LLPWellington Management Group LLP grew its stake in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 18.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,436,606 shares of the company's stock after purchasing an aDecember 9, 2024 | marketbeat.comJanus Henderson Group PLC Increases Stake in Zai Lab Limited (NASDAQ:ZLAB)Janus Henderson Group PLC raised its holdings in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 34.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,760,074 shares of the company's stock aDecember 4, 2024 | marketbeat.comBamco Inc. NY Has $46.02 Million Stake in Zai Lab Limited (NASDAQ:ZLAB)Bamco Inc. NY increased its position in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 6.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,906,520 shares of the company's stock after purchasing an adDecember 3, 2024 | marketbeat.comZai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic CancerDecember 2, 2024 | businesswire.comZai Lab's AUGTYRO For ROS1+ NSCLC Added To China's National Reimbursement Drug ListNovember 28, 2024 | markets.businessinsider.comAlgert Global LLC Invests $1.67 Million in Zai Lab Limited (NASDAQ:ZLAB)Algert Global LLC acquired a new stake in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 69,000 shares of the company's stock, valued at approximately $1,666,000November 28, 2024 | marketbeat.comZai Lab Announces the Inclusion of AUGTYRO® (repotrectinib) for ROS1+ NSCLC and Other Updates in China’s National Reimbursement Drug ListNovember 27, 2024 | finance.yahoo.comZai Lab Announces the Inclusion of AUGTYRO® (repotrectinib) for ROS1+ NSCLC and Other Updates in China's National Reimbursement Drug ListNovember 27, 2024 | businesswire.comZai Lab, Pfizer enter collaboration for XacduroNovember 21, 2024 | markets.businessinsider.comZai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO ® (Sulbactam-Durlobactam)November 21, 2024 | businesswire.comConnor Clark & Lunn Investment Management Ltd. Has $14.58 Million Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB)Connor Clark & Lunn Investment Management Ltd. lifted its stake in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 26.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 604,153 shares of the company's stoNovember 21, 2024 | marketbeat.comZai Lab Announces Completion Of Offering Of About 7.8 Mln ADSs, Stock DownNovember 18, 2024 | markets.businessinsider.comZai Lab Announces Anticipated Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters' Option to Purchase Additional American Depositary SharesNovember 18, 2024 | businesswire.comFY2024 EPS Estimates for Zai Lab Increased by AnalystZai Lab Limited (NASDAQ:ZLAB - Free Report) - Research analysts at Cantor Fitzgerald upped their FY2024 earnings per share (EPS) estimates for shares of Zai Lab in a note issued to investors on Wednesday, November 13th. Cantor Fitzgerald analyst L. Chen now forecasts that the company will post eaNovember 18, 2024 | marketbeat.comAnalyst Estimates: Here's What Brokers Think Of Zai Lab Limited (NASDAQ:ZLAB) After Its Third-Quarter ReportNovember 15, 2024 | finance.yahoo.comZai Lab 7.84M share Secondary priced at $25.50November 15, 2024 | markets.businessinsider.comWhy Zai Lab (ZLAB) Stock Is Trading HigherNovember 15, 2024 | benzinga.comZai Lab (NASDAQ:ZLAB) Sees Large Volume Increase - Still a Buy?Zai Lab (NASDAQ:ZLAB) Sees Unusually-High Trading Volume - Time to Buy?November 15, 2024 | marketbeat.comLeerink Partnrs Has Positive View of Zai Lab FY2024 EarningsZai Lab Limited (NASDAQ:ZLAB - Free Report) - Equities research analysts at Leerink Partnrs boosted their FY2024 EPS estimates for shares of Zai Lab in a research note issued to investors on Tuesday, November 12th. Leerink Partnrs analyst J. Chang now forecasts that the company will earn ($2.55)November 15, 2024 | marketbeat.comZai Lab Announces Pricing of Public Offering of American Depositary SharesNovember 14, 2024 | businesswire.comZai Lab Third Quarter 2024 Earnings: EPS Beats ExpectationsNovember 14, 2024 | finance.yahoo.comZai Lab (NASDAQ:ZLAB) Shares Gap Down - Should You Sell?Zai Lab (NASDAQ:ZLAB) Shares Gap Down - Time to Sell?November 14, 2024 | marketbeat.comZai Lab announces $200M American depositary shares offeringNovember 14, 2024 | markets.businessinsider.comZai Lab’s Strategic Advancements and Pipeline Successes Support Buy RecommendationNovember 14, 2024 | markets.businessinsider.comZai Lab Reports Strong Q3 Growth and Pipeline ProgressNovember 14, 2024 | markets.businessinsider.comZai Lab Launches $200 Million Public OfferingNovember 14, 2024 | markets.businessinsider.comZai Lab Announces Proposed Public Offering of American Depositary SharesNovember 14, 2024 | finance.yahoo.comZai Lab Ltd (ZLAB) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Path to ProfitabilityNovember 13, 2024 | finance.yahoo.comZai Lab and argenx announce NMPA approval for sBLA for VYVGART HytruloNovember 12, 2024 | finance.yahoo.comZai Lab Q3 2024 Earnings PreviewNovember 12, 2024 | msn.comZai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate UpdatesNovember 12, 2024 | businesswire.comArgenx, Zai Lab announce approval of VYVGART Hytrulo in ChinaNovember 11, 2024 | markets.businessinsider.comZai Lab, argenx Take in China NodNovember 11, 2024 | baystreet.caZai Lab, Argenx announce China NMPA approval for Vyvgart Hytrulo sBLANovember 11, 2024 | markets.businessinsider.comZai Lab gets expanded Chinese approval for Vyvgart HytruloNovember 11, 2024 | msn.comZai Lab (NASDAQ:ZLAB) Shares Gap Up - What's Next?Zai Lab (NASDAQ:ZLAB) Shares Gap Up - What's Next?November 11, 2024 | marketbeat.comZai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in ChinaNovember 11, 2024 | businesswire.comZai Lab (ZLAB) Set to Announce Earnings on TuesdayZai Lab (NASDAQ:ZLAB) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=481578)November 5, 2024 | marketbeat.comZai Lab Limited (NASDAQ:ZLAB) Holdings Trimmed by Mirae Asset Global Investments Co. Ltd.Mirae Asset Global Investments Co. Ltd. decreased its holdings in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 94.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,517 shares of theNovember 5, 2024 | marketbeat.comZai Lab presents positive outcomes from KarXT Phase III trial for schizophreniaOctober 30, 2024 | finance.yahoo.comZai Lab reports positive Chinese study data for KarXT for schizophreniaOctober 30, 2024 | seekingalpha.comZai Lab presents data from Phase 3 of KarXT for schizophrenia in ChinaOctober 30, 2024 | markets.businessinsider.comZai Lab Reports Positive Topline Data from Phase 3 Bridging Trial Evaluating KarXT for the Treatment of Schizophrenia in ChinaOctober 29, 2024 | businesswire.comZai Lab (NASDAQ:ZLAB) Receives Overweight Rating from Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating on shares of Zai Lab in a research report on Friday.October 25, 2024 | marketbeat.comZai Lab (NASDAQ:ZLAB) Stock Price Down 3.7% - Time to Sell?Zai Lab (NASDAQ:ZLAB) Trading Down 3.7% - Time to Sell?October 25, 2024 | marketbeat.comZai Lab, A Top 6% Stock, Launched To A 16-Month High On Its 'Impressive' ResultsOctober 25, 2024 | msn.comZai Lab presents data from ZL-1310 studyOctober 25, 2024 | markets.businessinsider.comHennion & Walsh Asset Management Inc. Acquires 18,093 Shares of Zai Lab Limited (NASDAQ:ZLAB)Hennion & Walsh Asset Management Inc. lifted its holdings in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 14.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 142,189 shares of the company's stock afOctober 25, 2024 | marketbeat.com Get Zai Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address This Crypto Is Set to Explode in December (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW ZLAB Media Mentions By Week ZLAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZLAB News Sentiment▼0.000.60▲Average Medical News Sentiment ZLAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZLAB Articles This Week▼04▲ZLAB Articles Average Week Get Zai Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Qiagen News Intra-Cellular Therapies News Roivant Sciences News Ascendis Pharma A/S News Revolution Medicines News Lantheus News Nuvalent News Legend Biotech News Blueprint Medicines News Elanco Animal Health News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZLAB) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zai Lab Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Zai Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
